$16.75
1.338.63%
Last update: Nov 10, 5:34 PM
Lyell Immunopharma Inc
LYELNASDAQ
Lyell Immunopharma fell 12.8% from $17.68 to $15.42, behind the S&P 500's +10.0%. Its worst day was Jun 3 (−15.6%), and its low came Oct 13 at $7.51.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-2.13 beat the $-2.71 estimate on $15,000.00 revenue.
−1.2% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
Lyell Immunopharma shares rose 18.8%, while the S&P 500 rose 1.5%.
+18.8% · S&P 500 +1.5%
Lyell Immunopharma closed at its highest level of the year, 118.3% above where the year started.
+3.4% · S&P 500 +0.4%
EPS of $-7.68 missed the $-2.20 estimate on $6,000.00 revenue (est. $20,330.00).
−14.2% · S&P 500 −0.6%
EPS of $-1.10 beat the $-2.45 estimate on $2,000.00 revenue (est. $4,400.00).
−3.8% · S&P 500 −0.3%
Lyell Immunopharma shares fell 15.6%, while the S&P 500 fell 0.7%.
−15.6%, the year's worst day · S&P 500 −0.7%
EPS of $-1.92 beat the $-2.00 estimate on $4,000.00 revenue (est. $4,600.00).
+3.5% · S&P 500 +0.6%
Lyell Immunopharma shares rose 16.5%, while the S&P 500 fell 0.7%.
+16.5% · S&P 500 −0.7%
Lyell Immunopharma closed at its lowest level of the year, 57.5% below where the year started.
−9.2% · S&P 500 0.0%
EPS of $-1.86 beat the $-1.92 estimate on $3,000.00 revenue (est. $3,290.00).
−2.8% · S&P 500 −4.4%
Where it ended: a close of $15.42 on Nov 9, 2026.
Nothing in the past 12 months.
All LYEL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LYEL and SPY from Benzinga historical bars. Not investment advice.
